VNDA (Vanda Pharma) Rega marang bathi mangsa ngarep

Vanda Pharmaceuticals (VNDA) specializes in the development and commercialization of medications for the correction of mental disorders. The business relies on holding exclusive rights to psychiatric and sleep therapies, which guarantees consistent demand. This chart of the F/PE ratio currently reflects a level of 0.00. High pricing is sustained by the company's dominance in the rare disease segment.

Kapitalisasi marang proyeksi bathi: Vanda Pharma (VNDA) kanggo 04.07.2022 - 14.11.2026

Rincian metrik lan analitis perusahaan Vanda (VNDA)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Vanda Pharmaceuticals Inc.|VNDA - Konsensus nilai wajar

- indikator valuasi pasar bisnis:

Nilai pasar Vanda Pharma|VNDA - Nilai Wutuh Bisnis

- data ekuitas miturut neraca:

Aset Bersih saben Siji Saham Vanda Pharmaceuticals|VNDA - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih vandapharma.com|VNDA - Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal Vanda Pharmaceuticals|VNDA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Vanda Pharmaceuticals|VNDA - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Vanda Pharma|VNDA - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Vanda Pharmaceuticals|Rasio cepet vandapharma.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

VNDA - Bathi resik|Bathi sing dikarepake Vanda Pharmaceuticals|VNDA - Pangali rega marang bathi|Pangali Forward P/E Vanda Pharmaceuticals Inc|VNDA - Rasio P/E diaturake wutah|Pangali EV/EBITDA Vanda Pharma|VNDA - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Vanda Pharmaceuticals|VNDA - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan vandapharma.com|VNDA - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Vanda Pharmaceuticals

- data pendapatan lan penerimaan dodolan:

VNDA - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Vanda Pharmaceuticals Inc.|VNDA - Multiplikator P/S|Rasio rega marang prakiraan pendapatan Vanda Pharma

Pambiji fundamental:VNDA Vanda Pharmaceuticals Inc.

Investors should employ position stress testing to assess capital resilience against market volatility. Vanda Pharmaceuticals (VNDA) is developing the biopharmaceutical sector by integrating strict environmental standards into its supply chains. The ratio of the current price to expected earnings on the company's forward P/E chart reflects market yield expectations. An increasing multiple signals inflated expectations, while a decrease indicates stagnation. This allows for an assessment of the cost-effectiveness of laboratory energy efficiency.

Pesaing Vanda Pharmaceuticals (VNDA)

Prakiraan rega marang bathi ALKS (Alkermes)|AVDL (Avadel Pharmaceuticals PLC) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep atai Life Sciences Corp ATAI|GHRS (GH Research Group) - Rasio rega marang bathi sing dikarepake|MNMD - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi compasspathways.com CMPS|LBRX (LB Pharmaceuticals) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Bright Minds Bio (DRUG)|CYBN (Cybin Inc) - Pangali Forward P/E|Prakiraan rega marang bathi Alto Neuroscience Corp (ANRO)|Pangali Forward P/E NRXP|CING (cingulate.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Silo Pharma, Inc. SILO|China Pharma Holdings Inc. (CPHI) - Rasio prakiraan rega marang bathi|CMND: Prakiraan rega marang bathi|PBM: Rega marang bathi mangsa ngarep|SPRC: Pangali Forward P/E|seelostherapeutics.com (SEEL) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Virpax Pharmaceuticals Inc.|Rasio rega marang bathi mangsa ngarep KRTX (Karuna Therapeutics Inc)